Skip to main content
. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206

Table 2.

Risk of bias summary for randomized studies (RoB 2) that used Ivermectin.

Study Bias from the Randomization Process Bias Due to Deviations from Intended Interventions Bias Due to Missing Outcome Data Bias in the Measurement of the Outcomes Bias in Selection of the Reported Result Overall Risk of Bias
Okumuş et al. (2021) [17] High Low Low High High High
Shakhsi et al. (2021) [18] Some concerns Low Low High High High
Beltran Gonzalez et al. (2022) [19] Low Low Low Low Low Low
Heydari et al. (2022) [20] Low Low Low Low Some concerns Some concerns
Lim et al. (2022) [21] Low Low Low Low Low Low
Quadeer et al. (2021) [22] Some concerns Some concerns Low High Low High
Rezai et al. (2022) [23] Low Low Low Low Low Low
Baghbanian et al. (2023) [24] Low Some concerns Low Low Low Some concerns